Pilot Study 1

Pilot Study 1 Lead Issaka will partner with Harborview Medical Center, part of UW Medicine, to assess the acceptability, feasibility, and demand for a ride-share transportation program for patients with abnormal fecal immunochemical test (FIT). Due to the need for procedural sedation, transportation is a frequently cited determinant to colonoscopy completion and is likely a contributor to lack of FIT follow-up.

Ride-share platforms are potentially scalable and cost-effective strategies if rides are scheduled by the health care team, costs are billed to the organization and utilization does not require individual smartphone ownership. However, ride-share programs to address this transportation determinant to screening completion can be designed in different ways, with differing effectiveness.

Using OPTICC Stage III methods, this study will explore ride-share employee, patient and provider perspectives on different ride-share program models. A ride-share program optimized for patient acceptability and demand and provider acceptability and feasibility can be tested in a subsequent trial for effectiveness in reducing disparities in follow-up of abnormal FIT.

Patient co-developed ride-share option with a signal of acceptability, feasibility, and demand that can be tested in a large scale trial.